display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
la/mBC - TNBC - L1 - PDL1 positive
nab-paclitaxel plus toripalimab TORCHLIGHT PDL 1 positive population

Study type: